AMS — Advanced Medical Solutions Balance Sheet
0.000.00%
- £492.51m
- £556.24m
- £177.52m
- 83
- 22
- 74
- 65
Annual balance sheet for Advanced Medical Solutions, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 53.8 | 73 | 82.3 | 60.2 | 17 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 19.5 | 20.9 | 20.4 | 22.7 | 51.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 97.2 | 115 | 132 | 122 | 126 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 30.1 | 27.4 | 29 | 29.6 | 45.9 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 239 | 250 | 281 | 289 | 388 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14.7 | 17 | 22.7 | 21.6 | 44.3 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 36.3 | 36.8 | 44.5 | 45 | 148 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 202 | 213 | 237 | 244 | 241 |
| Total Liabilities & Shareholders' Equity | 239 | 250 | 281 | 289 | 388 |
| Total Common Shares Outstanding |